Intermittent Fasting and Autophagy
Intermittent fasting (IF) is a dietary approach that involves restricting food intake for specific periods, alternating with periods of unrestricted eating. It has gained significant attention in recent years due to its potential health benefits, including weight loss, improved glucose control, and increased lifespan. One of the mechanisms by which IF may confer health benefits is through autophagy, a natural cellular process that helps remove damaged or dysfunctional cellular components. In this article, we will explore the science behind autophagy and IF, as well as the current research and data supporting their relationship.
What is autophagy?
Autophagy, from the Greek words auto (self) and phagein (to eat), is a cellular process by which cells break down and recycle damaged or dysfunctional cellular components, including proteins, organelles, and lipids. This process plays a critical role in maintaining cellular homeostasis and preventing the accumulation of damaged or misfolded proteins, which can lead to the development of neurodegenerative diseases, cancer, and other age-related conditions.
There are three types of autophagy: microautophagy, chaperone-mediated autophagy, and macroautophagy (hereafter referred to as autophagy). Autophagy is the most well-studied and best-understood form of autophagy. It involves the formation of a double-membraned vesicle called an autophagosome, which engulfs cellular components targeted for degradation. The autophagosome fuses with a lysosome, a specialized cellular organelle containing enzymes that break down cellular components, to form an autolysosome. The cellular components are then broken down into their constituent parts, which can be recycled or used for energy.
What is intermittent fasting?
Intermittent fasting is a dietary approach that involves alternating periods of fasting and feeding. There are several different approaches to IF, but the most common include:
Time-restricted feeding: This approach involves restricting food intake to a specific window of time each day. For example, an individual may fast for 16 hours each day and eat within an 8-hour window.
Alternate-day fasting: This approach involves alternating between a day of unrestricted eating and a day of fasting, where no or minimal calories are consumed.
Periodic fasting: This approach involves fasting for extended periods, typically several days to a week, followed by a period of unrestricted eating.
The goal of IF is to induce a state of mild stress on the body, which activates several cellular pathways involved in maintaining cellular homeostasis and promoting health.
Autophagy and intermittent fasting
One of the cellular pathways activated by IF is autophagy. During fasting, the body's energy stores are depleted, and cells must rely on alternative sources of energy, such as stored fat. This triggers a cascade of cellular responses, including the activation of autophagy.
Several studies have demonstrated that IF can increase autophagy in various tissues, including the liver, muscle, and brain. In one study, researchers found that alternate-day fasting increased autophagy in the hippocampus, a region of the brain involved in learning and memory. Another study found that periodic fasting increased autophagy in the liver, leading to improved glucose control and decreased liver fat accumulation.
While the exact mechanism by which IF induces autophagy is not fully understood, it is thought to be related to the activation of several cellular signaling pathways, including the AMP-activated protein kinase (AMPK) pathway and the mammalian target of rapamycin (mTOR) pathway. AMPK is a cellular energy sensor that is activated during times of low energy availability, such as fasting. AMPK activates autophagy by phosphorylating several key autophagy regulators. Conversely, mTOR is a cellular growth regulator that is activated during times of nutrient availability, such as feeding. mTOR inhibits autophagy by phosphorylating several key autophagy regulators. Therefore, during fasting, AMPK is activated, and mTOR is inhibited, leading to an increase in autophagy.
Benefits of autophagy
Autophagy plays a critical role in maintaining cellular homeostasis and preventing the accumulation of damaged or misfolded proteins. Dysfunction in the autophagy process has been linked to the development of several age-related diseases, including Alzheimer's disease, Parkinson's disease, and cancer. Therefore, enhancing autophagy through dietary or pharmacological interventions may have significant health benefits.
Several studies have demonstrated that autophagy induction can improve various health outcomes, including:
Aging: Aging is a complex process characterized by a decline in cellular and physiological functions. Autophagy has been shown to play a critical role in the aging process. Several studies have demonstrated that enhancing autophagy through dietary or pharmacological interventions can increase lifespan in various organisms, including mice, fruit flies, and worms.
Neurodegenerative diseases: Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, are characterized by the accumulation of misfolded proteins in the brain. Autophagy plays a critical role in clearing these proteins. Several studies have demonstrated that enhancing autophagy can improve outcomes in animal models of neurodegenerative diseases.
Cancer: Autophagy has a dual role in cancer development. In the early stages of cancer, autophagy can prevent the accumulation of damaged proteins and promote cell survival. However, in later stages of cancer, autophagy can promote tumor growth by providing nutrients to the cancer cells. Therefore, modulating autophagy may be a promising strategy for cancer prevention and treatment.
Metabolic disorders: Autophagy plays a critical role in maintaining glucose and lipid homeostasis. Dysfunction in autophagy has been linked to the development of metabolic disorders, such as obesity, type 2 diabetes, and non-alcoholic fatty liver disease. Therefore, enhancing autophagy through dietary or pharmacological interventions may be a promising strategy for treating these conditions.
Current research on intermittent fasting and autophagy
The relationship between IF and autophagy has been studied extensively in animal models and in vitro studies. However, there is limited human data on this topic. Nevertheless, several studies have suggested that IF can increase autophagy in humans.
In one study, researchers found that time-restricted feeding (16:8) increased autophagy markers in healthy adults. Another study found that alternate-day fasting increased autophagy markers in overweight adults. However, the results of these studies should be interpreted with caution, as they were small and short-term. Larger and longer-term studies are needed to confirm these findings.
In addition to increasing autophagy, IF has been shown to have several other health benefits, including weight loss, improved glucose control, and decreased inflammation. However, it is important to note that IF may not be suitable for everyone, especially those with a history of disordered eating or certain medical conditions. Therefore, individuals should consult with a healthcare provider before starting IF.
Conclusion
Autophagy is a critical cellular process that helps maintain cellular homeostasis and prevent the accumulation of damaged or misfolded proteins. IF has been shown to increase autophagy in various tissues, which may contribute to its health benefits. However, more research is needed to fully understand the relationship between IF and autophagy in humans. Nevertheless, the available evidence suggests that IF may be a promising dietary intervention for promoting health and preventing age-related diseases.
References:
Mizushima, N., & Komatsu, M. (2011). Autophagy: renovation of cells and tissues. Cell, 147(4), 728-741. https://doi.org/10.1016/j.cell.2011.10.026
Singh, R., & Cuervo, A. M. (2011). Autophagy in the cellular energetic balance. Cell Metabolism, 13(5), 495-504. https://doi.org/10.1016/j.cmet.2011.04.004
Madeo, F., Tavernarakis, N., & Kroemer, G. (2010). Can autophagy promote longevity?. Nature Cell Biology, 12(9), 842-846. https://doi.org/10.1038/ncb0910-842
Mizushima, N., & Levine, B. (2010). Autophagy in mammalian development and differentiation. Nature Cell Biology, 12(9), 823-830. https://doi.org/10.1038/ncb0910-823
Rubinsztein, D. C., Marino, G., & Kroemer, G. (2011). Autophagy and aging. Cell, 146(5), 682-695. https://doi.org/10.1016/j.cell.2011.07.030
Mattson, M. P., Longo, V. D., & Harvie, M. (2017). Impact of intermittent fasting on health and disease processes. Ageing Research Reviews, 39, 46-58. https://doi.org/10.1016/j.arr.2016.10.005
de Cabo, R., & Mattson, M. P. (2019). Effects of intermittent fasting on health, aging, and disease. New England Journal of Medicine, 381(26), 2541-2551. https://doi.org/10.1056/nejmra1905136
Alirezaei, M., Kemball, C. C., Flynn, C. T., Wood, M. R., Whitton, J. L., & Kiosses, W. B. (2010). Short-term fasting induces profound neuronal autophagy. Autophagy, 6(6), 702-710. https://doi.org/10.4161/auto.6.6.12376
Heilbronn, L. K., Civitarese, A. E., Bogacka, I., Smith, S. R., Hulver, M., & Ravussin, E. (2005). Glucose tolerance and skeletal muscle gene expression in response to alternate day fasting. Obesity Research, 13(3), 574-581. https://doi.org/10.1038/oby.2005.61
Wan, R., Ahmet, I., Brown, M., Cheng, A., Kamimura, N., & Talan, M. (2010). Cardioprotective effect of intermittent fasting is associated with an elevation of adiponectin levels in rats. Journal of Nutritional Biochemistry, 21(5), 413-417. https://doi.org/10.1016/j.jnutbio.2009.01.020
Horne, B. D., Muhlestein, J. B., & Anderson, J. L. (2015). Health effects of intermittent fasting: hormesis or harm? A systematic review. The American Journal of Clinical Nutrition, 102(2), 464-470. https://doi.org/10.3945/ajcn.115.109553